The European Hematology Association (EHA)

EHA Meetings

EHA-HKSH Hematology Tutorial

EHA is joining the Hong Kong Society of Hematology (HKSH) to organize the EHA-HKSH Hematology Tutorial on Lymphoid Malignancies.

Date: April 5-6, 2025
Location: Hong Kong
Format: In-Person

Goal of the meeting

This EHA-led hematology tutorial on Lymphoid Malignancies is an educational meeting aimed at deepening the knowledge of hematology trainees and fellows in the diagnosis and management of lymphoid malignancy; understanding the recent innovation and new developments in the field; and building the network with local and international experts in furthering hematology care and research in the region.

Target audience

Hematologists; hematology trainees and fellows from Hong Kong and the Asia Pacific region.

Program

Topics that will be covered are:

  • WHO classification of lymphomas
  • Follicular B cell lymphoma
  • Aggressive B cell lymphoma
  • T cell lymphoma and Anaplastic large cell lymphoma
  • Hodgkin lymphoma
  • Pathological diagnosis of lymphoma
  • CLL and related disorders
  • Acute lymphoblastic leukemia
  • CAR-T cell therapy
  • NK Cell lymphoma, EBV-related lymphoma, and PTLD

The full program is available on the meeting program page.

Learning objectives

After attending this tutorial, the participants will be able to:

  • gain enhanced ability to manage common forms of B cell and T/NK cell lymphoma; and Hodgkin lymphoma, both in the frontline and relapse setting;
  • benefit from the capability to choose between treatment options, novel agents, immunotherapy, or BMT appropriate to disease biology and patient profile

Venue

Hong Kong Convention and Exhibition Centre
1 Expo Drive, Wan Chai, Hong Kong Island

EBAH CME Accreditation

EBAH accredited stamp DEF2

EHA Hematology Tutorials are accredited by the European Board for Accreditation in Hematology (EBAH) CME. EBAH CME is the best way for hematologists to master the latest developments within the specialty of hematology. Staying abreast of these scientific developments and keeping in touch with up-to-date views on clinical policy will enable you to raise your professional level, resulting in the best treatment for your patients.